GZERO World Clips
Should you get the J&J vaccine? Why Dr. Atul Gawande says yes

Should You Get the J&J Vaccine? Why Biden Adviser Dr. Atul Gawande Says Yes | GZERO World

On Thursday, February 4, Johnson & Johnson requested emergency FDA approval for its single-shot vaccine. In the days since the company first released efficacy and safety data, many of the headlines focused on its lower efficacy rate compared to that of mRNA vaccines from Pfizer and Moderna. But that's the wrong takeaway, says surgeon, public health expert and former member of Biden-Harris Transition COVID-19 Advisory Board, Dr. Atul Gawande. "This is a highly effective vaccine. It stops people from getting sick. If some people have some sniffles and mild effects from the coronavirus, that's okay, this is going to stop the deadly disease. And that is the ultimate goal of the vaccine."
Gawande's conversation with Ian Bremmer is part of the latest episode of GZERO World, whichstarts airing on public television nationwide beginning this Friday, February 5th. Check local listings.
Even as Israel grows increasingly isolated on the world stage, there is one region where a whole swath of newly-elected leaders can't seem to get enough of the Jewish State: Latin America.
Prime Minister Giorgia Meloni has deployed 500 troops to Milan and tightened nationwide anti-rioting laws in an effort to quell unrest that has gripped the city since the weekend.
President Trump has changed course on Ukraine before. We all remember the Oval Office pyrotechnics (and the reconciliation). But his latest turn toward Russia could prove harder to reverse.
South Sudan is accusing neighboring Sudan of launching a drone strike that killed at least 73 people at a market in Abyei, a disputed, oil-rich region of roughly 4,000 square miles claimed by both countries.